Rion Co., Ltd. (TYO:6823)
Japan
· Delayed Price · Currency is JPY 2,484.00
0.00 (0.00%)
Apr 28, 2025, 3:30 PM JST
Rion Co., Ltd. Revenue
In the fiscal year ending March 31, 2025, Rion Co., Ltd. had annual revenue of 27.88B JPY with 8.36% growth. Rion Co., Ltd. had revenue of 7.39B in the quarter ending March 31, 2025, with 2.34% growth.
Revenue
27.88B
Revenue Growth
+8.36%
P/S Ratio
1.10
Revenue / Employee
27.01M
Employees
1,026
Market Cap
30.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27.88B | 2.15B | 8.36% |
| Mar 31, 2024 | 25.73B | 1.86B | 7.78% |
| Mar 31, 2023 | 23.87B | 1.23B | 5.45% |
| Mar 31, 2022 | 22.64B | 2.17B | 10.60% |
| Mar 31, 2021 | 20.47B | -999.00M | -4.65% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Daiichi Sankyo Company | 1,886.26B |
| Takeda Pharmaceutical Company | 4,579.02B |
| HOYA Corporation | 838.60B |
| Terumo | 1,011.15B |
| Otsuka Holdings | 2,329.86B |
| Astellas Pharma | 1,912.32B |
| Olympus | 993.33B |